Opinion

Video

Current Landscape of First-Line Treatment for Limited-Stage SCLC: Diagnostic Workup & Multidisciplinary Approaches

Panelists discuss how the current landscape of first-line treatment for limited-stage small cell lung cancer is shaped by various clinical factors that influence the diagnostic workup and management, emphasizing the importance of a multidisciplinary team approach in developing effective treatment plans for these patients.

Video content above is prompted by the following:

  1. Briefly explore the current landscape of first-line treatmentfor limited-stage small cell lung cancer (LS-SCLC):
  • What clinical factors influence the initial diagnostic workup and managementof patients with LS-SCLC? 
  • To what degree is a multidisciplinary team approach adopted when developing a treatment plan for patients with LS-SCLC? 
Related Videos
Jean L. Koff, MD, MS, associate professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute
Minoo Battiwalla, MD, MS, director, Blood Cancer Outcomes Research, Sarah Cannon Research Institute, TriStar Medical Group
Oleg Gluz, MD
Andrea Necchi, MD, associate professor, oncology, Vita-Salute San Raffaele University, director, Genitourinary Medical Oncology, IRCCS San Raffaele Hospital and Scientific Institute
Shirish M. Gadgeel, MD
Cynthia X. Ma, MD, PhD
Jacob Sands, MD
John K. Lee, MD, PhD
Alexandra Drakaki, MD, PhD
Kathleen A. Dorritie, MD